General Information of Drug Transporter (DT)
DT ID DTD0477 Transporter Info
Gene Name SLC8A1
Transporter Name Sodium/calcium exchanger 1
Gene ID
6546
UniProt ID
P32418
Post-Translational Modification of This DT
Overview of SLC8A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Palmitoylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

44

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC8A1 Asparagine 44 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

160

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC8A1 Asparagine 160 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8A1 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

592

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC8A1 Cystine 592 has the potential to affect its expression or activity.

Palmitoylation

  Cysteine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Increasing the participation of SLC8A1 in membrane domain-dependent endocytosis [3]

Role of PTM

Surface Expression Modulation

Modified Residue

Cysteine

Modified Location

739

Experimental Method

Co-Immunoprecipitation

Detailed Description

Palmitoylation at SLC8A1 Cysteine 739 have been reported to increase its participation in membrane domain-dependent endocytosis.

Phosphorylation

  Serine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8A1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

93

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 93 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8A1 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

101

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 101 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC8A1 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

284

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 284 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC8A1 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

285

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 285 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC8A1 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

392

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 392 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC8A1 [5] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

407

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 407 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC8A1 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

455

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 455 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC8A1 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

690

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Serine 690 has the potential to affect its expression or activity.

  Threonine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8A1 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

107

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 107 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8A1 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

122

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 122 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC8A1 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC8A1 [6] , [10]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

287

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 287 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC8A1 [10] , [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

398

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 398 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC8A1 [9] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

401

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 401 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC8A1 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

689

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Threonine 689 has the potential to affect its expression or activity.

  Tyrosine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC8A1 [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

259

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Tyrosine 259 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC8A1 [15] , [16]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

261

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Tyrosine 261 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC8A1 [17]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

351

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Tyrosine 351 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC8A1 [17]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

574

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC8A1 Tyrosine 574 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NAC1_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Palmitoylation of the Na/Ca exchanger cytoplasmic loop controls its inactivation and internalization during stress signaling. FASEB J. 2015 Nov;29(11):4532-43.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
6 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
7 CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
8 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
9 Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages. Mol Cell Proteomics. 2016 Oct;15(10):3203-3219.
10 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
11 Integrative network analysis of signaling in human CD34(+) hematopoietic progenitor cells by global phosphoproteomic profiling using TiO2 enrichment combined with 2D LC-MS/MS and pathway mapping. Proteomics. 2013 Apr;13(8):1325-33.
12 Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017 Mar 28;18(13):3242-3256.
13 Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
14 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
15 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
16 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
17 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.